Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylcholine translocator ABCB4 is a member of the ATP-binding cassette (ABC) transporter family, specifically mediating the ATP-dependent translocation ("flop") of phosphatidylcholine from the inner to the outer leaflet of the canalicular membrane in hepatocytes, thereby facilitating the secretion of phosphatidylcholine into bile. This activity is essential for normal bile formation and protects biliary epithelium from detergent effects of bile salts. Structural studies reveal conformational states where lipid binding, recruitment, and extrusion are coupled to ATP binding and hydrolysis. Mutations in ABCB4 cause inherited cholestatic disorders, and its function can be inhibited by drugs such as posaconazole, leading to adverse hepatic effects[3][7]. ABCB4 activity is crucial for lipid homeostasis and liver health.
Inhibition of phosphatidylcholine translocation (e.g., by binding and blocking lipid recruitment or extrusion)[3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylcholine translocator ABCB4 (ABCB4).